The global vitreoretinal surgery devices market is anticipated to grow at a significant CAGR of 5.2% during the forecast period. The growing demand for vitreoretinal surgery devices is primarily attributed to the growing incidence of retinal detachment(RD) and the increasing prevalence of diabetic retinopathy. According to the American Academy of Ophthalmology, diabetic retinopathy is the leading cause of blindness among working-age adults, and the prevalence of DR in patients with type 1 diabetic Mellitus is 77.3% and with type 2 is 25.1%, across the globe. As per the same source, Developed countries such as South America have a greater prevalence of diabetic retinopathy. Hence, the rising prevalence of such diseases contributes to the higher growth demand for the global vitreoretinal surgery devices market.
Browse the full report description of “Global Vitreoretinal Surgery Devices Market Size, Share & Trends Analysis Report by Product Type (Perfluorocarbon Liquids, Endoillumination Instrument, Vitreoretinal Prefilled Silicone Oil Syringes, and Others), and by Surgery Type (Anterior Vitreoretinal Surgery, and Posterior Vitreoretinal Surgery) Forecast 2022-2028” at https://www.omrglobal.com/industry-reports/vitreoretinal-surgery-devices-market
Moreover, the growing number of retinal disorders has led to an increase in the number of manufacturers and distributors, which are focusing on adopting different strategies such as mergers and acquisitions, partnership, innovation and new launch to stay competitive in the market.For instance, in October 2021, BVI announced an investment in Beyeonics Vision, a medical technology subsidiary of Elbit System Ltd. With this investment Beyeonics Vision aims to use an integrated augmented reality (AR), tracking, and image processing/AI platform to deliver improved visualization.Through this collaboration, the company aims to expand their our collective capabilities to optimize all aspects of visualization for eye surgeons and offer a transformative experience to providers and patients.
Apart from this, in July 2021, Johnson & Johnson Vision, globally launched a VERITAS Vision System, which is a next-generation phacoemulsification (phaco) system. Phacoemulsification is the commonly demandedcataract surgery technique thatallows surgeons to effectively emulsify and efficiently remove the eye’s internal lens.
Market Coverage
• The market number available for – 2021-2028
• Base year- 2021
• Forecast period- 2021-2028
• Segment Covered-
o By Product Type
o By Surgery Type
• Regions Covered-
o North America
o Europe
o Asia-Pacific
o Rest of the World
• Competitive Landscape-includesBausch + Lomb Corp., Glaukos Corp., Hoya Corp., Johnson & Johnson Vision Care Inc., STAAR Surgical Co., MEDA Co. Ltd., MedOne Surgical, Inc., Nidek Co., Ltd., and others
Key questions addressed by the report
• What is the market growth rate?
• Which segment/region dominates the market in the base year?
• Which segment/region will project the fastest growth in the market?
• How has COVID-19 impacted the market?
o Recovery Timeline
o Deviation from the pre-COVID forecast
o Most affected region/segment
• Who is the leader in the market?
• How players are addressing challenges to sustain growth?
• Where is the investment opportunity?
Global Vitreoretinal Surgery Devices Market– Segmentation
By Product Type
By Surgery Type
Global Vitreoretinal Surgery Devices Market by Region
North America
• US
• Canada
Europe
• Germany
• United Kingdom
• France
• Spain
• Italy
• Rest of Europe
Asia-Pacific
• China
• Japan
• India
• Rest of Asia-Pacific
Rest of the World
• Middle East & Africa
• Latin America
To learn more about this report request a free sample copy @ https://www.omrglobal.com/request-sample/vitreoretinal-surgery-devices-market